Fay, a dietitian startup that offers personalized nutrition plans and consultations, raised $30 million to expand its services and integrate Ozempic, a diabetes medication, into its platform. The funding round was led by General Catalyst and Forerunner Ventures. (Published by ...
Fay raised $30 million to expand its services and integrate Ozempic
Jun 20, 2024
—